1Squadrito G,Previti M, Lenzi M, et al. High prevalence of non organ specific autoantibodies in hepatitis C virus infected cirrhotic patients from southern Italy[J]. Dig Dis Sci, 2003,48 (2) :349-353.
6Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.Hepatology, 2000, 31: 1005-1013.
7Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmane hepatitis. J Hepatol, 1999, 31: 929-938.
8Leung PS, Van de Water J, Coppel RL, et al. Molecular aspects and the pathological basis of primary biliary cirrhosis. J Autoimmun,1996, 9: 119-128.
9Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet, 1996,348: 1399-1402.
10Thomsen BL, Sorensen TI. Analysis of the treatment effect on recurrent bleeding and death in patients with cirrhosis and esophageal varices: multistage competing-risks model compared to conventional methods. J Hepatol, 1998, 28: 107-114.
